Latest filing published 18 May 2020 for Altimmune, Inc., €754k.
Filing timeline
BuySaleInsider track record
Velocity Pharmaceutical Holdings LLC: trading record in brief
Velocity Pharmaceutical Holdings LLC discloses dealings in Altimmune, Inc. to SEC (Form 4). We count 2 filings; the first trade dates from 14 May 2020 and the latest from 15 May 2020.
Every open-market trade on record is a sale: 2 sales worth €886k.
The record was last updated on 18 May 2020 with an open-market sale (€754k) in Altimmune, Inc. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Velocity Pharmaceutical Holdings LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 169,378 shares@ US$4.8185.1% of flowCommon StockSEC:0000899243-20-013395:0
- 30,622 shares@ US$4.6514.9% of flowCommon StockSEC:0000899243-20-013395:1
2 of 2 declarations
